The Novo Nordisk A/S (NYSE:NVO) attempt to block Mylan Pharmaceuticals from launching a generic version of its weight-loss drug Wegovy hit a major obstacle as the court ruled in Mylan's favor on key ...
With a new patent settlement, generic partners Mylan and Natco have cleared one hurdle to a potential U.S. launch of their generic to Novo Nordisk's wildly popular Type 2 diabetes drug Ozempic. Mylan ...
A Mérignac, il y a les Rafale, les Falcon mais aussi la Bétadine ! C'est en effet sur le site girondin de Mylan qu'est fabriqué ce célèbre antiseptique lancé en 1970. Il y est produit sous toutes ses ...
Mylan beat Sanofi's anti-competitive claims U.S. judge in Kansas weighing dispute June 29 (Reuters) - Drugmaker Sanofi (SASY.PA), opens new tab asked a U.S. judge on Wednesday to curb Mylan's bid to ...
STATEWIDE — New York Attorney General Letitia James’ office has helped to secure a multistate settlement in principle with the successor company of pharmaceutical manufacturer Mylan Inc. that will ...
Mylan Pharmaceuticals, Inc. has agreed to pay $335 million to settle a national lawsuit over its role in the opioid crisis, the Utah Attorney General's Office announced Monday. The company, which ...
PORTLAND, Ore. — Pharmaceutical company Mylan Inc. is expected to pay more than $4 million to Oregon to help address the opioid crisis, Oregon Attorney General Dan Rayfield announced on Tuesday. It's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback